Catalyst
Description
  • Value proposition

    We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth.

    We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time.

    Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

    vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare

  • Original language

    We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth.

    We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time.

    Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

  • R&D-Driven and AI-Powered Biopharmaceutical Company | Sanofi

    R&D-Driven and AI-Powered Biopharmaceutical Company | Sanofi

  • https://www.sanofi.com/en
Entity interactions
Entity TypeTweets Articles
Département NMNS UPR 4301 Département NMNS UPR 4301
Research Services, deeptech
Other
Fark Labs Fark Labs
Research Services
Other

5 Mar 2026


NVDIAG LabCom NVDIAG LabCom
Research Services, healthtech, biotech, deeptech
Other

31 Jan 2026


initiative OCTALFA initiative OCTALFA
Business Consulting and Services, healthtech
Other

25 Mar 2026


SFIP SFIP
greentech, Plastics Manufacturing
Other

4 Mar 2026


Takara Capital Takara Capital
Venture Capital and Private Equity Principals
Other

3 Mar 2026


IRDI Capital Investissement IRDI Capital Investissement
Venture Capital and Private Equity Principals
Other

24 Mar 2026


RRHHDigital RRHHDigital
Online Media
Other

16 Mar 2026


Volies Global Volies Global
Business Consulting and Services, consulting
Other

8 Mar 2026


hospitalmanager hospitalmanager
Book and Periodical Publishing
Other

6 Mar 2026


Radars
Loading...